Clinical Trials in Houston

Showing 7201-7220 of 13,620 trials

TruGraf® Testing in High-Risk Kidney Transplant Recipients

NCT04266613

This is an observational study to evaluate TruGraf® testing in high immune risk kidney transplant recipients. TruGraf is the first and only non-invasive test approved by Medicare to rule out silent rejection in stable kidney transplant recipients.

Kidney Transplant Rejection

Transplant Genomics, Inc.19 participantsStarted Feb 2020

Houston, Texas, United States

COMPLETEDPhase 1/2< 1 mile

Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

NCT02471716

This is a phase 1/2 single arm, open-label, safety, tolerability, and PK study of cabiralizumab in PVNS/dt-TGCT patients.

Pigmented Villonodular SynovitisTenosynovial Giant Cell Tumor

Five Prime Therapeutics, Inc.66 participantsStarted Jun 2015

Los Angeles, California, United States • Santa Monica, California, United States • Stanford, California, United States +9 more locations

COMPLETEDPhase 1< 1 mile

Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT02715011

The purpose of this study is to characterize the safety and tolerability of JNJ-63709178 and identify the recommended Phase 2 dose(s) (RP2D) and schedule for JNJ-63709178 in Part 1 and to characterize the safety and tolerability of JNJ-63709178 at the RP2D(s) in Part 2.

Leukemia, Myeloid, Acute

Janssen Research & Development, LLC62 participantsStarted Jun 2016

Detroit, Michigan, United States • New York, New York, United States • Charlotte, North Carolina, United States +7 more locations

TruGraf® Testing in High-Risk Kidney Transplant Recipients

Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Find Trials by Condition in Houston

Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis

Pain and Anxiety Management With Oral Narcotic for Pediatric Suture Repair

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

St.Jude Medical Cardiac Lead Assessment Study

Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD)

A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis

Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers